HCC Response Assessment by MRI After SBRT

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

October 1, 2011

Primary Completion Date

April 1, 2013

Study Completion Date

February 1, 2015

Conditions
Carcinoma, Hepatocellular
Interventions
RADIATION

SBRT delivers high dose selective irradiation with millimeter precision to a small volume. The Cyberknife® is a robotic SBRT dedicated device that can deliver 100 to 200 photobeams to the target

Seven to ten days before the scheduled CT, 2-4 fiducial markers were implanted percutaneously 2 to 5 cm next to the lesion under sonographic guidance following administration of local anesthesia, thus allowing real-time tracking during treatment. The total dose delivered was 45 Gy on the 80% isodose, in three fractions over 10 days. Gross tumor volume (GTV) was defined as the tumor mass that could be discerned by diagnostic imaging. An isotropic margin of 5 mm was added to account for the microscopic extension (clinical target volume, CTV) and another 3 mm margin was added to compensate for uncertainties regarding the position (previsional target volume, PTV)

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT03088423 - HCC Response Assessment by MRI After SBRT | Biotech Hunter | Biotech Hunter